Literature DB >> 15045127

Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.

Andreas Zirlik1, Anne Leugers, Jens Lohrmann, Sandra Ernst, Burton E Sobel, Christoph Bode, Thomas K Nordt.   

Abstract

Adipose tissue produces substantial amounts of plasminogen activator inhibitor type-1 (PAI-1), an established cardiovascular risk factor. This study evaluated PAI-1 expression in human adipose tissue in response to thiazolidinediones, insulin sensitising drugs activating peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Troglitazone, rosiglitazone, and ciglitazone significantly reduced PAI-1 protein expression in human preadipocytes under basal conditions and after stimulation of the cells with TGF-beta. Pioglitazone had no effect. In human adipocytes all four thiazolidinediones significantly attenuated PAI-1 expression. Signalling appeared to be mediated via PPAR-gamma and effects reflected, at least in part, changes in transcription. Accordingly, patients with insulin resistance may benefit from treatment with thiazolidinediones with respect to diminution of PAI-1 expression in adipose tissue and consequent potential reduction of cardiovascular risk.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15045127     DOI： 10.1160/TH03-06-0384

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  12 in total

Review 1.  Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.

Authors:  James H O'Keefe; Mohammad Abuannadi; Carl J Lavie; David S H Bell
Journal:  Mayo Clin Proc       Date:  2011-01-26       Impact factor: 7.616

2.  PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.

Authors:  R Marcucci; D Brogi; F Sofi; C Giglioli; S Valente; A Alessandrello Liotta; M Lenti; A M Gori; D Prisco; R Abbate; G F Gensini
Journal:  Heart       Date:  2005-07-01       Impact factor: 5.994

3.  Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.

Authors:  Yoshiyuki Rikitake; James K Liao
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

Review 4.  Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

Authors:  Gianluca L Perrucci; Erica Rurali; Aoife Gowran; Alessandro Pini; Carlo Antona; Roberto Chiesa; Giulio Pompilio; Patrizia Nigro
Journal:  Cell Mol Life Sci       Date:  2016-08-17       Impact factor: 9.261

Review 5.  Are thiazolidinediones good or bad for the heart?

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

6.  Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.

Authors:  G-H Hao; X-L Niu; D-F Gao; J Wei; N-P Wang
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

Review 7.  Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.

Authors:  Susanne Trost; Richard Pratley; Burton Sobel
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

8.  Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study.

Authors:  Frances M K Williams; Angela M Carter; Bernet Kato; Mario Falchi; Lise Bathum; Gabriela Surdulescu; Kirsten Ohm Kyvik; Aarno Palotie; Tim D Spector; Peter J Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

9.  Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.

Authors:  Vijayalakshmi Varma; Aiwei Yao-Borengasser; Angela M Bodles; Neda Rasouli; Bounleut Phanavanh; Greg T Nolen; Emily M Kern; Radhakrishnan Nagarajan; Horace J Spencer; Mi-Jeong Lee; Susan K Fried; Robert E McGehee; Charlotte A Peterson; Philip A Kern
Journal:  Diabetes       Date:  2007-12-05       Impact factor: 9.461

10.  Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.

Authors:  Jie Huang; Maria Sabater-Lleal; Folkert W Asselbergs; David Tregouet; So-Youn Shin; Jingzhong Ding; Jens Baumert; Tiphaine Oudot-Mellakh; Lasse Folkersen; Andrew D Johnson; Nicholas L Smith; Scott M Williams; Mohammad A Ikram; Marcus E Kleber; Diane M Becker; Vinh Truong; Josyf C Mychaleckyj; Weihong Tang; Qiong Yang; Bengt Sennblad; Jason H Moore; Frances M K Williams; Abbas Dehghan; Günther Silbernagel; Elisabeth M C Schrijvers; Shelly Smith; Mahir Karakas; Geoffrey H Tofler; Angela Silveira; Gerjan J Navis; Kurt Lohman; Ming-Huei Chen; Annette Peters; Anuj Goel; Jemma C Hopewell; John C Chambers; Danish Saleheen; Per Lundmark; Bruce M Psaty; Rona J Strawbridge; Bernhard O Boehm; Angela M Carter; Christa Meisinger; John F Peden; Joshua C Bis; Barbara McKnight; John Öhrvik; Kent Taylor; Maria Grazia Franzosi; Udo Seedorf; Rory Collins; Anders Franco-Cereceda; Ann-Christine Syvänen; Alison H Goodall; Lisa R Yanek; Mary Cushman; Martina Müller-Nurasyid; Aaron R Folsom; Saonli Basu; Nena Matijevic; Wiek H van Gilst; Jaspal S Kooner; Albert Hofman; John Danesh; Robert Clarke; James B Meigs; Sekar Kathiresan; Muredach P Reilly; Norman Klopp; Tamara B Harris; Bernhard R Winkelmann; Peter J Grant; Hans L Hillege; Hugh Watkins; Timothy D Spector; Lewis C Becker; Russell P Tracy; Winfried März; Andre G Uitterlinden; Per Eriksson; Francois Cambien; Pierre-Emmanuel Morange; Wolfgang Koenig; Nicole Soranzo; Pim van der Harst; Yongmei Liu; Christopher J O'Donnell; Anders Hamsten
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.